Platelet-Rich Plasma: A Milieu of Bioactive Factors

被引:472
作者
Boswell, Stacie G. [1 ]
Cole, Brian J. [2 ]
Sundman, Emily A. [1 ]
Karas, Vasili [2 ]
Fortier, Lisa A. [1 ]
机构
[1] Cornell Univ, Coll Vet Med, Dept Clin Sci, Ithaca, NY 14853 USA
[2] Rush Univ, Med Ctr, Chicago, IL 60612 USA
关键词
GROWTH-FACTOR; IN-VITRO; LEUKOCYTE GEL; ACTIVATION; GRANULES; PRP; CONCENTRATE; AGGREGATION; NEUTROPHILS; INHIBITION;
D O I
10.1016/j.arthro.2011.10.018
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
100224 [整形外科学];
摘要
Platelet concentrates such as platelet-rich plasma (PRP) have gained popularity in sports medicine and orthopaedics to promote accelerated physiologic healing and return to function. Each PRP product varies depending on patient factors and the system used to generate it. Blood from some patients may fail to make PRP, and most clinicians use PRP without performing cell counts on either the blood or the preparation to confirm that the solution is truly PRP. Components in this milieu have bioactive functions that affect musculoskeletal tissue regeneration and healing. Platelets are activated by collagen or other molecules and release growth factors from alpha granules. Additional substances are released from dense bodies and lysosomes. Soluble proteins also present in PRP function in hemostasis, whereas others serve as biomarkers of musculoskeletal injury. Electrolytes and soluble plasma hormones are required for cellular signaling and regulation. Leukocytes and erythrocytes are present in PRP and function in inflammation, immunity, and additional cellular signaling pathways. This article supports the emerging paradigm that more than just platelets are playing a role in clinical responses to PRP. Depending on the specific constituents of a PRP preparation, the clinical use can theoretically be matched to the pathology being treated in an effort to improve clinical efficacy.
引用
收藏
页码:429 / 439
页数:11
相关论文
共 85 条
[1]
Effects of time of day and acute resistance exercise on platelet activation and function [J].
Ahmadizad, Sajad ;
El-Sayed, Mahmoud S. ;
MacLaren, Donald P. .
CLINICAL HEMORHEOLOGY AND MICROCIRCULATION, 2010, 45 (2-4) :391-399
[2]
The effects of estrone, estradiol and estriol on platelet aggregation induced by adrenaline and adenosine diphosphate [J].
Akarasereenont, Pravit ;
Tripatara, Pinpat ;
Chotewuttakorn, Sirikul ;
Palo, Titchaporn ;
Thaworn, Athiwat .
PLATELETS, 2006, 17 (07) :441-447
[3]
Fibroblastic response to treatment with different preparations rich in growth factors [J].
Anitua, E. ;
Sanchez, M. ;
Zalduendo, M. M. ;
de la Fuente, M. ;
Prado, R. ;
Orive, G. ;
Andia, I. .
CELL PROLIFERATION, 2009, 42 (02) :162-170
[4]
Bachl N, 2009, J SPORT MED PHYS FIT, V49, P346
[5]
Molecular Basis of Anti-Inflammatory Action of Platelet-Rich Plasma on Human Chondrocytes: Mechanisms of NF-κB Inhibition Via HGF [J].
Bendinelli, Paola ;
Matteucci, Emanuela ;
Dogliotti, Giada ;
Corsi, Massimiliano M. ;
Banfi, Giuseppe ;
Maroni, Paola ;
Desiderio, Maria Alfonsina .
JOURNAL OF CELLULAR PHYSIOLOGY, 2010, 225 (03) :757-766
[6]
Bhaskar Shobha, 2010, Indian J Physiol Pharmacol, V54, P141
[7]
Bhattacharyya S, 2008, J BONE MINER RES, V23, P1106, DOI [10.1359/jbmr.080235, 10.1359/JBMR.080235]
[8]
Platelet-Rich Plasma Concentrate to Augment Bone Fusion [J].
Bibbo, Christopher ;
Hatfield, P. Shawn .
FOOT AND ANKLE CLINICS, 2010, 15 (04) :641-649
[9]
Platelet α-granules: Basic biology and clinical correlates [J].
Blair, Price ;
Flaumenhaft, Robert .
BLOOD REVIEWS, 2009, 23 (04) :177-189
[10]
Granules of the human neutrophilic polymorphonuclear leukocyte [J].
Borregaard, N ;
Cowland, JB .
BLOOD, 1997, 89 (10) :3503-3521